Koyfin Home > Directory > Health Care > Aimmune Therap > Long-Term Debt / Capital

Aimmune Therap Long-Term Debt / Capital Chart (AIMT)

Aimmune Therap annual/quarterly Long-Term Debt / Capital from 2018 to 2020.
  • Aimmune Therap Long-Term Debt / Capital for the quarter ending June 06, 2020 was $44m a 43.21% increase of 19m year over year
  • Aimmune Therap Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $44m a 43.21% increase of 19m year over year
  • Aimmune Therap Annual Long-Term Debt / Capital for 2019 was $33m a 99.94% increase of 33m from 2018
  • Aimmune Therap Annual Long-Term Debt / Capital for 2018 was $0m
Other Ratios Metrics:
  • Aimmune Therap Total Debt / Capital for the quarter ending December 12, 2017 was $0m
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Debt / Equity for the quarter ending December 12, 2017 was $0m
View Chart On Koyfin

Quarterly AIMT Long-Term Debt / Capital Data

06/2020$44m
03/2020$37m
12/2019$33m
09/2019$25m
06/2019$19m
03/2019$16m
12/2018$0m

Annual AIMT Long-Term Debt / Capital Data

2019$33m
2018$0m